The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Neogenomics Inc (NASDAQ: NEO) was $9.91 for the day, up 1.64% from the previous closing price of $9.75. In other words, the price has increased by $1.64 from its previous closing price. On the day, 1.28 million shares were traded.
Ratios:
Our analysis of NEO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.89 and its Current Ratio is at 1.98. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.44.
On December 10, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $22.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 15 ’24 when Olivo Alicia C sold 5,175 shares for $15.36 per share. The transaction valued at 79,475 led to the insider holds 37,129 shares of the business.
ALICIA OLIVO bought 5,175 shares of NEO for $81,713 on Nov 15 ’24. On Aug 15 ’24, another insider, Olivo Alicia C, who serves as the General Counsel of the company, sold 1,040 shares for $16.05 each. As a result, the insider received 16,695 and left with 43,813 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.93 while its Price-to-Book (P/B) ratio in mrq is 1.41.
Stock Price History:
Over the past 52 weeks, NEO has reached a high of $19.11, while it has fallen to a 52-week low of $8.05. The 50-Day Moving Average of the stock is -2.98%, while the 200-Day Moving Average is calculated to be -30.16%.
Shares Statistics:
A total of 128.15M shares are outstanding, with a floating share count of 127.12M. Insiders hold about 1.20% of the company’s shares, while institutions hold 101.27% stake in the company.
